Lee Shapiro

Lee Shapiro is a declared insider at 5 companies; the most frequent names are Veradigm Inc., Livongo Health, Inc. and Medidata Solutions, Inc. We count 154 filings; the first trade dates from 1 March 2005 and the latest from 6 January 2025.

On the open market, the record shows 7 purchases worth €515k and 28 sales worth €30.0M. Netting one side against the other leaves €29.5M of net selling. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 55 share grants and 21 option exercises.

Half of the purchases are above €45k and half below. Clusters matter here: 4 out of 5 purchases overlapped with buying by a colleague within 30 days. Purchases made close together by different insiders form what is called a cluster.

Most recently, on 8 January 2025, the filings show a share grant in Clover Health Investments, CORP. /de. The most recent open-market purchase was published on 15 March 2022, 1,699 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.